Medicine just got a digital upgrade:
Software-Enhanced Drugs™

We believe that software-enhanced drug™ formulations will change the pharmacotherapy landscape as we know it.

• Improve formulary positioning and prescriber preference with superior clinical outcomes.
• Enable the creation of measurable, data-driven value-based contracts for high-cost innovative therapies.
• Build personal relationships with patients that can persist over time.
• Collect de-identified real world data to generate new population-level insights.
• Empower patients to be at the center of their own treatment by helping them take charge of their condition.
• Deliver combined therapeutic impact on both biochemical targets (drugs) and neurocircuits and behavior (software).
• Promote long-lasting behavior change to support durability of treatment.
• Transfer pharmacological outcomes (e.g., cognition, metabolic health) to adjacent domains (e.g., problem solving, daily function).
• Pursue outcomes currently inaccessible to drug (e.g., mood, fatigue).
• Accelerate clinical study recruitment and improve clinical study designs using data-driven insights.
• Unlock a new domain of R&D to improve software-based drug™ treatment over time for continuous value creation.
• Offer providers a new way to interact with and understand their patients.
• Generate digital biomarkers to guide clinical decision making and clinical research.
• Providing patients with new clinical benefits not targetable by drug.
• Boosting persistence on treatment through engaging digital experience.
• Drive significant incremental economic value to the healthcare system.
• Provide patients with a differentiated treatment experience.
• Creating rich, longitudinal real-world datasets optimized for AI/ML and population insights.